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ABSTRACT 
Phaleria macrocarpa (Scheff.) Boerl. is a dense evergreen tree of the family Thymelaeceae. This plant is 
popular with the name of Mahkota dewa, which is literally translated as God’s Crown. All parts of this 
plant including fruits, seeds, stem, and leaves have well known therapeutic properties and have been 
extensively used in traditional medicine for the treatment of various diseases such as cancer, diabetes 
mellitus, allergies, kidney disorders, blood diseases, stroke, and acne with satisfactory results. Scientific 
findings on bioactivities of P. macrocarpa also demonstrated different pharmacological properties of 
various parts of this plant including cytotoxic, antidiabetic, antioxidant, anti-inflammatory, antibacterial, 
and antihypertensive activities. Phytochemicals studies of P. macrocarpa revealed the presence of several 
classes of compounds such as benzophenones, terpenoids, xanthones, lignans, acids, and sugars. This 
review aims to provide a critical overview on botanical description, traditional usage, phytochemicals, 
and pharmacological activities of P. macrocarpa. 
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INTRODUCTION 
 
Nature plays an important role in providing the basic needs of 
human in the production of food-stuffs, shelters, clothing, 
means of transportation, fertilizers, flavours and fragrances, 
and, not the least, medicines for the treatment of various 
diseases (Cragg and Newmann, 2013; Gordaliza, 2007). 
Mineral, animal and plant products were utilized as the main 
sources of drugs, and the use of natural products with 
therapeutic properties is as ancient as human civilization (De 
Pasquale, 1984; Rates, 2001; Samuelsson, 2004). Most of the 
plant compounds that have been found to be medicinally useful 
and interesting tend to be secondary metabolites including 
alkaloids, phenolics, acetogenins and terpenoids. Secondary 
metabolites represent features that can be expressed in terms of 
ecological, taxonomic and biochemical differentiation and 
diversity. The wide chemical diversity of secondary metabolites 
throughout the plant kingdom represents an extremely rich 
biogenic resource for the discovery of novel drugs and for 
developing innovative remedies (Gurib-Fakim, 2006). To date, 
natural products and their derivatives represent more than 50% 
of all the drugs in clinical use in the world. Higher plants 
contribute no less than 25% of the total. During the last 40 
years, at least a dozen potent drugs were reported from 
flowering plants (Gurib-Fakim, 2006). 
The Thymelaeaceae family is a cosmopolitan family of 
flowering plants, which is established by Hanus-Fajerska et al. 
(2012). This family consists of 45 genera and 700 - 800 species, 
and is widely distributed in both hemispheres (Herber, 2002; 
2003). Nine genera and 89 species of the Thymelaeaceae plants 
are endemic to China (Zheng et al., 1999). In the other large 
genera of the Thymelaeaceae are Gnidia with approximate 
number of species 160, Pimelea (110), Daphne (95), 
Wikstroemia (70), Daphnopsis (65), Struthiola (35), Lachnaea 
(30), Thymelaea (30), Phaleria (30), and Gonystylus (25) 
(Kubitzki and Bayer, 2003). The species of this family include 
mostly shrubs or small trees, rarely herbs, evergreen or 
deciduous. Most species are toxic but some have medicinal 
properties. The phloem contains strong fibers, which make the 
bark of many species beneficial in manufacturing of high 
quality paper especially bank notes. The stems have 
characteristics of supple and are difficult to break, and used as a 
substitute for string (Zheng et al., 1999). One of the plants 
within the Thymelaeceae is Phaleria macrocarpa (Scheff.) 
Boerl. which was first described by Scheffer as Drimyspermum 
macrocarpum based on fruiting specimens collected by 
Teysmann near Doré, in western New Guinea (Angiosperm 
Phylogeny Group, 2003). The other botanical name of this 
plant is Phaleria papuana Warb var. Wichanii (Val) Back (Hou, 
1960). This plant is popular with the name of ‘Mahkota dewa’, 
which is literally translated as God’s Crown. It is locally known 
as ‘Simalakama’ in Sumatra (Malay) and Depok (West Java) 
and ‘Makutadewa’, ‘Makuto rajo’, ‘Makuto ratu’ or ‘Makuto 
mewo’ in Java (Harmanto, 2005). 
 
 
Botanical descriptions of P. macrocarpa (Scheff.) Boerl. 
P. macrocarpa is a shrub or small tree that grows throughout 
the year. This plant usually reaches the height of 5 m but 
sometimes its height could also reach up to 18 m (Harmanto, 
2003; Stevens, 1974; Winarto, 2003). It grows in areas of 10 – 
1,200 m above the sea level and the most productive age of this 
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plant is in between 10 – 20 years (Saufi, 2007). The plant of P. 
macrocarpa has features of many-branched crown with 1-metre 
long straight root exuding sap, a brownish green bark and white 
wood. The leaves are green, sharp edge and tapering from 10 - 
15 cm in length and 3 – 5 cm in wide (Fig. 1A). Its flowers 
appear in white colour with trumpet-like shape and produce 
pleasant smell. The fruits have an eclipse shape; occur in 
various sizes with diameter ranging from 3 – 5 cm. Its fruits 
have smooth surface and changing their colour from green 
when young into red or maroon when ripening (Fig. 1B). The 
pit is round, white and poisonous (Fig. 1C) (Altaf et al., 2013; 
Hendra et al., 2011; Saufi, 2007) 
 
 
Traditional usage of various parts of P. macrocarpa (Scheff.) 
Boerl. 
P. macrocarpa is frequently used as a therapeutic healing 
alternative in health system of the Indonesians and lower 
course of Malaysia (Ali et al., 2012). All parts of this plant 
including fruits, seeds, stems and leaves have well known 
therapeutic properties and have been extensively used in 
traditional medicine (Tjandrawinata et al., 2010 Winarto, 2003). 
Specifically, the fruits of P. macrocarpa are used to treat flu, 
rheumatism, heart diseases and cancer; the leaves are used to 
treat dysentery, allergy, tumour and impotency while the stems 
are beneficial in the treatment of bone cancer. The eggshells of 
seeds are used to counter breast cancer, cervix cancer, lung 
disease, liver, and heart diseases. This plant especially the seed 
part cannot be consumed directly due to its high toxicity which 
can cause swelling, numbness and unconsciousness. However, 
the seeds can be used as an external medicine for the treatment 
of skin conditions and for ornamental cultivation purposes, 
which act as a traditional biopesticide (De Padua et al., 1999; 
Harmanto, 2003). 
 
Phytochemical studies 
Several research groups especially from Indonesia and China 
had extensively carried out studies to find chemical 
constituents from P. macrocarpa. The studies resulted in the 
isolation of several classes of compounds such as 
benzophenones, terpenoids, xanthones, lignans, acids and 
sugars. Chemical investigation on the fruits, leaves and bark of 
P. macrocarpa afforded eight benzophenone derivatives, 
identified as phalerin (1) (Altaf et al., 2013; Oshimi et al., 
2008), isophalerin A (2), isophalerin B (3) (Susilawati, 2012), 
Mahkoside A (4) (Zhang et al., 2006), Mahkoside B (5) (Zhang 
et al., 2012), 6,4'-dihydroxy-4-methoxybenzophenone-2-O-α-
D-glucopyranoside (6) (Tambunan and Simanjutak, 2006), 6,4'-
dihydroxy-4-methoxybenzophenone-2-O-β-D-glucopyranoside 
(7) (Susilawati, 2012; Winarno and Katrin, 2009) and 2,6,4'-
trihydroxy-4-methoxybenzophenone (8) (Simanjutak, 2008; 
Susilawati et al., 2011). Several triterpenoids derivatives known 
as icariside C3 (9) (Oshimi et al., 2008), phalerielide (10) 
(Susilawati, 2012), β-sitosterol (11), stigmasterol (12) and 
cyloargetanol (13) (Simanjutak, 2008) were successfully 
isolated from the fruits of P. macrocarpa. Phytochemical 
studies on the fruits by Kurnia et al. (2008) reported a new 29-
norcucurbitacin derivative named as desacetyl-fevicordin A 
(14), together with fevicordin A (15), fevicordin A glucoside 
(16) and fevicordin D glucoside (17). 
In addition, studies on chemical constituents from the fruits 
of P. macrocarpa revealed the isolation of an ester compound, 
ethyl stearate (18) (Zhang, 2006) and acid derivatives including 
palmitic acid (19) (Simanjutak, 2008; Zhang et al., 2006), oleic 
acid (20), linoleic acid (21), linolineic acid (22), dodecanoic 
acid (23) (Simanjutak, 2008), naphtoic acid (24) (Susilawati, 
2012) and gallic acid (25) (Faried et al., 2007). A novel lignan 
named as macronone (26) (Susilawati et al., 2012) and a known 
lignan, syringaresinol (27) (Lisdawati et al., 2007) were 
obtained from the ethyl acetate extract of the bark and 
mesocarp of P. macrocarpa, respectively. The investigation on 
the chemical constituents of this plant yielded a xanthone and 
flavonoid compound identified as mangiferin (28) (Kim et al., 
2010; Oshimi et al., 2008; Zhang et al., 2006) and kaempferol-
3-O-β-D-glucoside (29) (Zhang et al., 2006). Moreover, two 
sugar molecules known as glucose (30) and sucrose (31) 
(Simanjutak, 2008; Zhang et al., 2006) were isolated from the 
aqueous extract of P. macrocarpa fruits. Furthermore, the 
quantitative analysis on various parts of P. macrocarpa fruits 
revealed the presence of five major flavonoids named as 
kaempferol (32), myricetin (33), quercetin (34), naringin (35), 
and rutin (36). Qualitative analysis of the flavonoids was 
carried out by reversed-phased high performance liquid 
chromatography (RP-HPLC) using an analytical column C18 
60Å 4μm, 3.9 × 150 mm, Waters, NANPA, MA (USA). The 
flavonoids were detected at 365 nm of UV-Vis photodiode 
array (DAD) detector (Hendra et al., 2011). 
 
Pharmacological activities 
Empirically, Indonesian people have as often utilized the fruits 
bark and leave of P. macrocarpa for the treatment of various 
diseases such as cancer, diabetes mellitus, allergies, kidney 
disorders, blood diseases, stroke and acne with satisfactory 
results. Therefore, many scientific evaluations on bioactivities 
of P. macrocarpa have been conducted in order to prove the 
traditional claims on the medicinal values of this plant. 
 
Anticancer activity 
Cytotoxic activities of the methanolic extract from different 
parts of P. macrocarpa fruits were evaluated against the human 
colon adenocarcinoma cell line (HT-29), human breast 
adenocarcinoma cell line (MCF-7), human cervical cell line 
(HeLa) and normal human hepatocytes cell line (Chang liver 
cell). The viability of cells was measured using the MTT assay. 
The fruits were divided into pericarp, mesocarp and seed. 
Results obtained indicated that all parts had potential cytotoxic 
activity against the MCF-7 and HeLa cancer cell lines with IC50 
values ranging from 25.5 – 40.8 µg/ml. The results also showed 
that the seeds exhibited potential cytotoxic effect against HT-29 
with an IC50 value of 29.5 µg/ml while the pericarp and 
mesocarp exhibited mild cytotoxicity with IC50 values between 
63.8 – 70.1 µg/ml (Hendra et al., 2011). 
An in vitro study on the cytotoxic effect of fruit extract was 
carried out against the human uterine cervical carcinoma cell 
line (HeLa) (Rahmawati et al., 2006). Various concentrations of 
fruit extract were used to determine the inhibition activity 
against the HeLa cell line after 24, 72 and 120 h of incubation. 
The results showed good inhibitory activity against the HeLa 
cell after 72 h of incubation with an IC50 value of 5.09 ppm 
(Pertamawati, 2007). Another investigation on the anticancer 
activity of the ethanol extract of the fruit pulps of P. 
macrocarpa against mouse mammary tumour was induced by 
transplantation. This study concluded that the ethanol extract 
did not inhibit the mouse mammary tumour growth at doses of  
 
Fig. 1. The (A) leaves, (B) fruit and (C) pit of P. macrocarpa 
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Table 1. Phytochemicals of P. macrocarpa according to its part and types of extract used 
No Name of compound Structure Plant part Types of extract References 
(1) Phalerin 
O
HO
HO
OH
OH
O
OH
H3CO OH
O
H
 
Fruits Chloroform Oshimi et al., 2008 
Leaves Methanol Altaf et al., 2013 
(2) Isophalerin A 
O
OH
OHH
OH
O
HO OH OCH3
O
OH
 
Fruits Ethyl acetate Susilawati, 2012 
(3) Isophalerin B 
O
HO
HO
H
OH
O
OH
O
HO OH OCH3
 
Leaves Ethyl acetate Susilawati, 2012 
(4) Mahkoside A 
O
HO
HO
H
OH
O
OH
O
OHO OH
CH3
 
Nutshell Ethyl acetate Zhang et al., 2006 
(5) Mahkoside B 
O
HO
HO
H
OH
O
OCH3
O
OHH3CO OH
 
Nutshell Ethyl acetate Zhang et al., 2012 
(6) 
6,4'-Dihydroxy-4- 
methoxybenzophenone-
2-O-α-D-
glucopyranoside 
O
OHHO
OH
OH
H
OH3CO
OH
OH
O  
Fruits 
n-butanol Tambunan and Simanjutak, 2006 
Aqueous Simanjutak, 2008 
(7) 
6,4'-Dihydroxy-4-
methoxybenzophenone-
2-O-β-D-
glucopyranoside 
O
HO
HO
H
OH
O
OH
O
OHH3CO OH
 
Fruits Ethyl acetate Susilawati, 2012 
Bark 
 
Ethyl acetate 
 
Winarno and Katrin, 2009 
(8) 
2,6,4'-Trihydroxy-4-
methoxybenzophenone 
OHH3CO
OH
OH
O  
Fruits Methanol Simanjutak, 2008 
Leaves Ethyl acetate Susilawati, 2011 
(9) Icariside C3 
O
OH
OH
HO
O
OH
OH
HO
 
Fruits Chloroform Oshimi et al., 2008 
(10) Phalerielide 
O
HOH2C
OCH3
OCH2OH
COOCH3H3CO
H3CO HO
O
HOH2CO
H
O
CH3
OH
HO
O
HO
 
Fruits Methanol Susilawati, 2012 
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Table 1. Phytochemicals of P. macrocarpa according to its part and types of extract used (continued) 
No Name of compound Structure Plant part Types of extract References 
(11) β-Sitosterol 
HO
 
Fruits Ethyl acetate Simanjutak, 2008 
(12) Stigmasterol 
HO  
Fruits Ethyl acetate Simanjutak, 2008 
(13) Cycloargetanol 
HO  
Fruits Ethyl acetate Simanjutak, 2008 
(14) Desacetyl-fevicordin A 
OH
O
HO
HO
O
OH
HO
H
 
Seed Ethyl acetate Kurnia et al., 2008 
(15) Fevicordin A 
OAc
O
HO
HO
O
OH
HO
H
 
Seed Ethyl acetate Kurnia et al., 2008 
(16) Fevicordin A glucoside 
OAc
O
HO
O
OH
HO
H
H
O
HO
O
HO
HO
OH
 
Seed Ethyl acetate Kurnia et al., 2008 
(17) Fevicordin D glucoside 
OH
O
HO
O
HO
H
H
O
HO
O
HO
HO
OH
OH
OH
OH
 
Seed Ethyl acetate Kurnia et al., 2008 
(18) Ethyl stearate 
O
O
 
Fruits Methanol Simanjutak, 2008 
(19) Palmitic acid COOH  Fruits 
Chloroform Oshimi et al., 2008 
n-Hexane Simanjutak, 2008 
(20) Oleic acid COOH  Fruits n-Hexane Simanjutak, 2008 
(21) Linoleic acid 
COOH  
Fruits n-Hexane Simanjutak, 2008 
(22) Linolineic acid 
COOH  
Fruits n-Hexane Simanjutak, 2008 
(23) Dodecanoic acid COOH  
Fruits n-Hexane Simanjutak, 2008 
(24) Naphtoic acid 
H3CO
OCH3COOH  
Fruits Ethyl acetate Susilawati, 2012 
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20, 40 and 80 fold human doses given orally after tumour 
transplantation for 30 days. However, the results demonstrated 
the significant increase of apoptosis atthe dose of 80 time 
human dose (Rahmawati et al., 2006). 
Previous cytotoxic study on the fruits of P. macrocarpa 
reported the non-toxic effect of the ethanol extract from the 
seeds and fruits flesh towards human mononuclear peripheral 
normal cell but slightly toxic to the vero cell line. The extract 
also did not increase p53 and decrease bcl-2 gene expression 
that suggested the mechanism of dying cell was caused by 
necrosis and not by apoptosis (Altaf R et al., 2013). Bioactivity 
study of irradiated P. macrocarpa leaves showed that the n-
hexane, ethyl acetate and methanol extracts exhibited strong 
cytotoxic effect against the mouse leukaemia L1210 cell line 
with IC50 values of 12.4 10.3 and 24.1 µg/ml, respectively 
(Katrin et al., 2011). In addition, cytotoxic activity of the n-
hexane, chloroform, ethyl acetate and methanol extracts from 
the leaves of P. macrocarpa plant were investigated against the 
human hepatoma cell lines (HepG2). The ethyl acetate and 
methanol extracts were found to have mild cytotoxic effect 
(IC50 32.5 and 40 µg/ml, respectively) (Yosie et al., 2011). 
The investigations on cytotoxic effects of isolated 
compounds were conducted against several cancer cell lines. 
Study on cytotoxic activity of phalerin (1) from the methanolic 
extract of P. macrocarpa leaves was investigated against the 
myeloma cell line (NS-1). Phalerin (1) was non-toxic towards 
NS-1 cell line (IC50 83µg/ml) (Altaf et al., 2013). Two 
benzophenone glucosides, mahkoside A (4) and mahkoside B 
(5) were found to have low cytotoxic effect towards several 
human cancer cell lines including the prostate cancer cell line 
(PC-3), stomach cancer cell line (MGC-803) and esophageal 
cancer cell lines (EC109 and EC9706), with IC50 values 
exceeding 100 µM/L (Zhang et al., 2012). However, the 
inhibitory activity of another benzophenone glucoside named 
as 6,4'-dihydroxy-4-methoxybenzophenone-2-O-β-D-gluco 
pyranoside (7) displayed that this compound had strong 
cytotoxic properties against the mouse leukaemia cell line 
(L1210) (IC50 5.1 µg/ml) (Winarno and Katrin, 2009). 
Additionally, fevicordin A (15) demonstrated strong anticancer 
properties against the murine leukaemia cell line (P388) and 
cervix cancer cell line (HeLa) (IC50 0.01 and 1.16 µg/ml, 
respectively). This compound also exhibited moderate 
anticancer activity against another cervix cancer cell line 
(CasKi) and oesophagus cancer cell line (TE-8) with IC50 
values of 12 and 14.6 µg/ml, respectively (Diantini et al., 2012). 
Faried et al. (2007) studied the anticancer properties of 
gallic acid (25), isolated from the fruits of P. macrocarpa. The 
cell proliferation activity was performed using the MTT assay 
against the human esophageal cancer cell line (TE-2), gastric 
Table 1. Phytochemicals of P. macrocarpa according to its part and types of extract used (continued) 
No Name of compound Structure Plant part Types of extract References 
(25) Gallic acid 
OH
HO OH
O OH
 
Fruits Ethyl acetate Faried et al., 2007 
(26) Macronone 
O
O
O
OHOH
OH
OHHO
HO
OH
O
O
 
Bark Ethyl acetate Susilawati, 2012 
(27) Syringaresinol 
O
O
OCH3
HO
HO
HO  
Fruits Ethyl acetate Lisdawati et al., 2007 
(28) Mangiferin O
HO
HO
OH
OH
O
O
HO OH
OH
OH  
Fruits 
Methanol Oshimi et al., 2008 
Ethyl acetate Zhang et al., 2006 
Leaves Aqueous Kim et al., 2010 
(29) 
Kaempferol-3-O-β-
D-glucoside 
O
OH
OH
HO
O
OH
O
O
HO
OH
OH
 
Fruits Ethyl acetate Zhang et al., 2006 
(30) Glucose OHO
HO
OH
OH
OH
 
Fruits Aqueous Simanjutak, 2008 
(31) Sucrose 
CH2OH
OH
O
OO CH2OH
OH
HO
HO
OH
H
 
Fruits 
Chloroform Zhang et al., 2006 
Aqueous Simanjutak, 2008 
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cancer cell line (MKN-28), colon cancer cell lines (HT-29 and 
Colo201), breast cancer cell line (MCF-7), cervix cancer 
cellline (CaSki), mouse colon cancer cell line (colon 26) with 
one normal human esophageal cell line (CHEK-1). 
Interestingly, gallic acid (25) showed significant anticancer 
properties towards all tested cancer cell lines and induced 
apoptosis in TE-2 cell line. Apart from the cytotoxic screening 
activities, the study on molecular mechanism of the extract 
from this plant on human breast cancer cell line (MDA-MB-
231) was performed using a bioactivity-guided DLBS1425. In a 
previous study, DLBS1425 was found to confer 
antiproliferative and proapoptosis effects via eicosanoid 
pathway (Tjandrawinata et al., 2010). DLBS1425 was shown as 
a potent anticancer agent that targets genes involved in cell 
survival and apoptosis in the MDA-MB-231 cell line 
(Tandrasasmita et al., 2010). 
 
Antidiabetic activities 
The investigation on the α-glucosidase inhibitory activity and 
hypoglycemic effect by oral administration of fruit extracts 
from P. macrocarpa in rats were evaluated (Sugiwati et al., 
2006). The highest α-glucosidase inhibitory activity was 
displayed by the n-butanol extract of young and ripe fruits 
followed by the ethyl acetate and methanol extracts. The boiled 
water and n-butanol extracts also displayed hypoglycemic 
effect by reducing the blood glucose concentration of rats with 
effective dose ranging between 1.0 × 10-3 – 6.5 × 10-3 mg/g. 
The results suggested that this plant could be suitable as a 
traditional antidiabetic drug (Sugiwati et al., 2006). The 
hypoglycemic activity of this plant was further investigated by 
evaluating the effect of the fruits powder on blood glucose 
levels in glucose loading healthy volunteers. The effective dose 
of mesocarp fruit powder to decrease the blood glucose level in 
healthy volunteers was significantly found at the concentration 
of 500 mg (Meiyanti et al., 2006). 
Another study revealed the potential of the ethyl acetate 
extract of fruits to improve insulin sensitivity in hyperglycemic 
rats by decreasing the blood glucose level. The highest activity 
of insulin activity was 18.3%, 9 min after the rats being 
injected with glucose and exogenous insulin (Muhtadi et al., 
2008). The in vitro mechanism study demonstrated the 
antidiabetic properties of the ethanol extract of the fruits as α-
glucosidase inhibitor and as insulin secretagog in clonal 
glucose responsive insulin secreting cell (BRIN-BD11). In the 
same study, the qualitative analysis of phytochemicals from the 
ethanol extract revealed the presence of flavonoid, alkaloid, 
tannin and steroid. Among these classes of compounds, 
flavonoid was suggested to be responsible for the antidiabetic 
properties of the extract in that study (Suparto et al., 2008). In 
addition, the methanol extract from the fruits pericarp was 
found to have potential anti-hyperglycemic effect by lowering 
blood glucose at 56.3% and 58.3% after 12 days of treatment.  
Table 2. Summary of pharmacological activities of chemical constituent from P. macrocarpa 
Activity Compound Assay Organism / cells used Results / Observation Reference 
Cytotoxic 
activity 
(1) MTT assay Myeloma cancer cell line (NS-1) 
Non-toxic towards NS-
1 cell line (IC50 83 μg/ml) 
Altaf et al., 
2013 
(4) 
Sulforhodamine 
B 
(SRB assay) 
Esophageal cancer cell lines  
(EC109 and EC9706),  
stomach cancer cell line  
(MGC-803),  
prostate cancer cell line (PC-3) 
Low cytotoxic effect against 
 PC-3, MGC-803,  
EC109 and EC9706 cell lines 
 (all IC50 >100μM/l) 
Zhang et al.,
 2012 
(5) 
(7) MTT assay Leukemia cancer cell line (L1210) 
Strong cytotoxic effect against L121
0 cell line (IC50 5.1 μg/ml) 
Winarno and 
Katrin,  
2009 
(15) MTT assay 
Murine leukemia cancer cell line  
(P388), cervix cancer cell lines  
(HeLa and CaSki),  
oesophagus cancer cell line (TE-8) 
-Strong anticancer properties 
against P388 (IC50 0.01 μg/ml) and 
HeLa cell lines (IC50 1.16 μg/ml) 
-
Moderate anticancer activity against
 CasKi (IC50 12 μg/ml) and TE-
8(IC50 14.6 μg/ml) 
Diantini  
et al., 2012 
(25) MTT assay 
Esophageal cancer cell line (TE-2), 
gastric cancer cell line (MKN-28), 
colon cancer cell lines  
(HT-29 and Colo201),  
breast cancer cell line (MCF-7),  
CaSki cell line, mouse colon cancer 
cell line (colon 26) 
Have significant anticancer 
properties against TE-2, MKN-28, 
HT-29, Colo201, MCF-7,  
CaSki and colon 26 cancer cell lines 
Faried et al.,
 2007 
Antioxidant 
activity 
(8) DPPH assay - 
Strong antioxidant activity  
(IC50 10.57 μg/ml) 
Susilawati  
et al., 2011 
(26) DPPH assay - 
Weak antioxidant activity  
(IC50 240.14 µg/ml) 
Susilawati  
et al., 2012 
Anti-
inflammatory 
activity 
(1) 
Lipoxygenase 
assay (LOX) 
 Hyaluronidase 
assay (HYA) 
Xanthine Oxida
se assay (XO) 
- 
-Displayed mild anti-inflammatory 
properties in XO and LOX assay 
with percentage of inhibition 
34.83% and 23.47%, respectively 
-
Does not exhibited as inflammatory 
effect on HYA assay 
Fariza et al., 
2012 
Vasorelaxant 
activity 
(1) 
Vasodilator  
assay 
Noradrenaline-induced contraction 
of isolated rat  
aorta 
No vasorelaxant effect 
Oshimi  
et al., 2008 
(9) Slow vasorelaxant activity 
(28) No vasorelaxant effect 
Toxicity 
activity 
(14) 
- Brine shrimp (A. Salina) 
All compounds showed variable tox
icity with LD50 ranging from 3 ppm 
– 12 ppm 
Kurnia  
et al., 2008 
(15) 
(16) 
(17) 
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Table 3. Summary of pharmacological activities of extracts from P. macrocarpa 
Activity Extract 
Plant 
part 
Assay / Method 
Organism / cells 
used 
Results / observation Reference 
Cytotoxic 
activity 
Methanol 
Pericarp, 
mesocarp 
and seed 
 
Colon cancer cell 
line (HT-29), breast 
cancer cell line 
(MCF-7), cervix 
cancer cell line 
(HeLa) 
-All parts show potential cytotoxic 
activity against the MCF-7 and 
HeLa cancer cell lines with IC50 
values ranging from 25.5 – 40.8 
µg/ml. 
 
- The seed part exhibited as 
potential cytotoxic effect against 
HT-29 with IC50 29.5 µg/ml while 
the pericarp and mesocarp exhibited 
as mild cytotoxicity with IC50 
between 63.8 – 70.1 µg/ml. 
Hendra et al., 
2011 
Ethanol Fruit 
Various 
concentrations 
of extract used 
to determine the 
inhibition 
activity after 24, 
72 and 120 
hours of 
incubation. 
Cervix cancer cell 
line (HeLa) 
 
Showed the good inhibition activity 
of HeLa cell occur after 72 hours of 
incubation with IC50 5.09 ppm 
Pertamawati, 
2007 
Ethanol 
Fruit 
pulp 
Silver colloidal 
stain (AgNOR) 
C3H mouse 
mammary tumour 
induced by 
transplantation 
-Did not inhibit the C3H mouse 
mammary tumour growth at dose 
20, 40 and 80 fold human dose 
given orally after tumour 
transplantation for 30 days. 
 
-The results demonstrated the 
significant increase of apoptosis at 
dose of 80 time human dose. 
Rahmawati et 
al., 2006 
Ethanol 
Fruit and 
seed 
MTT assay and 
imunocytochem
istry 
Human 
mononuclear perifer 
normal cell line and 
vero cell line 
-Non-toxic effect of ethanol extract 
from the seed and fruits flesh 
towards human mononuclear perifer 
normal cell but slightly toxic to vero 
cell line. 
-The ethanol extract also did not 
increase p53 and decrease bcl-2 
gene expression that suggested the 
mechanism of dying cell was caused 
by necrosis and not by apoptosis. 
Altaf et al., 
2013 
n-Hexane, 
ethyl acetate 
and 
methanol 
Irradiated 
leaves 
MTT assay 
Mouse leukemia 
cell line (L1210), 
The n-hexane, ethyl acetate and 
methanol extracts exhibited strong 
cytotoxic effect against mouse 
leukemia L1210 cell line with IC50 
12.4, 10.3 and 24.1 µg/ml, 
respectively. 
Katrin et al., 
2011 
n-Hexane, 
chloroform, 
ethyl acetate 
and methanol 
Leaves MTT assay 
Human hepatoma 
cell lines (HepG2) 
- The n-hexane and chloroform did 
not show cytotoxic effect 
-Ethyl acetate and methanol extracts 
were found to have significant mild 
cytotoxic effect with IC50 32.5 and 
40 µg/ml, respectively. 
Yosie et al., 
2011 
- - 
Bioactivity-
guided 
DLBS1425 
Breast cancer cell 
line  
(MDA-MB-231) 
Results suggested that DLBS1425 
exhibited as potent anticancer agent 
that targets genes involved in cell 
survival and apoptosis in MDA-
MB-231 cell line. 
Tandrasasmita 
et al., 2010 
and 
Tjandrawinat
a et al., 2010 
Antidiabetic 
activity 
n-Butanol, 
ethyl acetate, 
methanol and 
boiled water 
Fruit 
α-glucosidase 
inhibitory 
activity and 
hypoglycemic 
effect by oral 
administration 
in rats 
Male rats strain 
Wistar, about 6 
months old, weight 
250 – 350 g 
-The highest α-glucosidase 
inhibitory activity was shown by the 
n-butanol extract of young and ripe 
fruits followed by ethyl acetate and 
methanol extract. 
-The boiled water and n-butanol 
extracts were also found to have 
hypoglycemic effect by reducing the 
blood glucose concentration of rats 
with effective dose ranging between 
1.0 x 10-3 – 6.5 x 10-3 mg/g. 
Sugiwati et 
al., 2006 
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Table 3. Summary of pharmacological activities of extracts from P. macrocarpa (continued) 
Activity Extract Plant part Assay / Method 
Organism 
/ cells used 
Results / observation Reference 
Antidiabe
tic 
activity 
- 
Fruit 
powder 
Hypoglycemic activity 
on blood glucose levels 
in glucose loading 
healthy volunteers 
Healthy 
volunteers 
The effective dose of mesocarp fruit 
powder to decrease the blood 
glucose level in healthy volunteers 
was significantly found at 
concentration of 500 mg. 
Meiyanti et al., 
2006 
Ethyl acetate Fruit Insulin activity 
Male white 
mice, 3 - 4 
weeks old, 
weight 20-
30 g 
-The study revealed the potential of 
ethyl acetate extract to improve 
insulin sensitivity in hyperglycemic 
rats by decreasing the blood glucose 
level. 
-The highest activity of insulin 
activity was 18.3%, 9 min after the 
rats being injected with glucose and 
exogenous insulin. 
Muhtadi et al., 
2008 
Ethanol Fruit Insulin secretion assay 
Insulin 
secreting 
cell 
(BRIN-
BD11) 
The study has demonstrated the 
antidiabetic properties of ethanol 
extract as α-glucosidase inhibitor 
and as insulin secretagog in clonal 
glucose responsive insulin secreting 
cell (BRIN-BD11). 
Suparto et al., 
2008 
Methanol 
Fruits 
pericarp 
Anti-hyperglycemic 
activity 
Normal 
and 
diabetic 
rats 
The methanol extract was found to 
have potential anti-hyperglycemic 
effect by lowering blood glucose at 
56.3% and 58.3% after 12 days of 
treatment. 
Ali et al., 2012 
Methanol and 
water 
Fruits 
Protective effect of 
extracts on renal 
histological changes of 
alloxan-induced diabetes 
Male 
Sprague 
Dawly rats,  
6-8 weeks 
old, weight 
160 - 200 g 
Both extracts have potential to 
restore glomerular hypertrophy and 
improved glomeruloscierosis in 
alloxan-induced diabetes. 
Sulistyo-
ningrum 
et al., 2013 
Fraction: 
Methanol 
Subfractions: 
Chloroform, 
ethyl acetate, 
n-butanol and 
aqueous 
Fruits 
Bioassay-guided 
antidiabetic activity 
- 
-The study identified the sub-
fraction that which contain 
flavonoid in abundance. 
-The sub-fraction was proved to 
have potent antidiabetic activity by 
inhibiting rat intestinal glucose 
transportation and absorption. 
 
Atangwho et al., 
2012 
Anti-
inflammat
ory 
activity 
Pericarp, 
mesocarp and 
seed 
Fruits 
Nitric oxide (NO) 
synthesis induced by 
LPS/IFN-γ assay 
Macro-
phage 
RAW 264.7 
cell lines 
Extracts from pericarp and 
mesocarp showed notable anti-
inflammatory effect with 
percentage of inhibition 63.4% and 
69.5%, respectively. 
 
Hendra et al., 
2011 
Antioxida
nt activity 
Methanol and 
ethanol Different 
parts of 
young and 
old fruits 
DPPH assay - 
Most of the parts from young and 
old fruits showed potent antioxidant 
activity with scavenging inhibition 
ranging between 38.4 - 48.1%. 
 
Soeksmanto et 
al., 2007 
Ethyl acetate,     
n-butanol and 
water 
The highest antioxidant activity was 
shown by n-butanol extracts of 
young fruits with IC50 41.07 ppm. 
 
n-Hexane, 
chloroform, 
ethyl acetate 
and methanol 
Leaves DPPH assay - 
-The n-hexane and chloroform 
extracts were exhibited as moderate 
antioxidant properties with 
percentage of inhibition 59% and 
69%, respectively. 
- Ethyl acetate and methanol 
extracts were exhibited as strong 
antioxidant activity with percentage 
of inhibition 76% and 79%, 
respectively. 
Yosie et al., 
2011 
Methanol 
Pericarp, 
mesocarp 
and seed 
Ferric thiocyanate 
(FTC), thiobarbituric 
acid (TBA), radical 
scavenging method 
(DPPH), ferric-reducing 
antioxidant power 
(FRAP) and nitric oxide 
scavenging method (NO) 
- 
The results revealed the strong 
antioxidant properties of pericarp 
and mesocarp on FRAP assays with 
percentage inhibition of 92.35% 
and 78.78%, respectively. 
Hendra et al., 
2011 
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This finding led to phytochemical screening, revealing the 
presence of flavonoids, terpenoids, and tannins in the methanol 
extract. These classes of compounds were suggested to be the 
major contributors to its antidiabetic properties (Ali et al., 
2012). 
Sulistyoningrum et al. (2013) discovered the protective 
effect of the methanol and water extracts of P. macrocarpa on 
renal histological changes of alloxan-induced diabetes. The 
results concluded that both extracts were able to restore 
glomerular hypertrophy and improved glomeruloscierosis in 
alloxan-induced diabetes. Bioassay-guided antidiabetic study 
on the extract from the fruits successfully identified the active 
sub-fraction that had flavonoids in abundance. The sub-fraction 
was proved to have potent antidiabetic activity by inhibiting rat 
intestinal glucose transportation and absorption. (Atangwho et 
al., 2012). 
 
Anti-inflammatory activities 
Different parts of the fruits of P. macrocarpa were screened for 
their anti-inflammatory activity using the nitric oxide (NO) 
synthesis in macrophage RAW 264.7 cell lines induced by the 
LPS/IFN-γ assay. Extracts from the pericarp and mesocarp 
showed notable anti-inflammatory effect with percentage of 
inhibition of 63.4% and 69.5%, respectively (Hendra et al., 
2011). Study on anti-inflammatory activity was performed on 
the major compound from the fruits identified as phalerin (1). 
This compound showed low inflammatory effect since it 
decreased the inflammation twice lower than the standard, 
Napoxen at dose of 22.5 mg/kg body weight (Mariani et al., 
2010). Anti-inflammatory activity of phalerin (1) was also 
determined by using the lipoxygenase (LOX), hyaluronidase 
(HYA) and xanthine oxidase (XO) assays. The results showed 
that phalerin (1) had mild anti-inflammatory properties in the 
XO and LOX assays with percentage of inhibition 34.8% and 
23.5%, respectively. Meanwhile, phalerin (1) did not exhibit 
any inflammatory effect in the HYA assay (Fariza et al., 2012). 
 
Antioxidant activities 
Antioxidant activity of the methanol and ethanol extracts from 
different parts of young and old fruits of P. macrocarpa was 
evaluated using the free-radical-scavenging method (DPPH). 
Most of the parts from young and old fruits showed potent 
antioxidant activity with scavenging inhibition ranging between 
38.4 - 48.1%. Further fractionation of the active extracts was 
carried out to give ethyl acetate, n-butanol and water extracts. 
The highest antioxidant activity was observed in the n-butanol 
extract of the young fruits with IC50 of 41.07 ppm (Soeksmanto 
et al., 2007). The same DPPH method was also performed to 
determine the antioxidant activity of different polarity of 
extracts from the leaves of P. macrocarpa. Ethyl acetate and 
methanol extracts exhibited strong antioxidant activity with  
76% and 79% inhibitions, respectively. Meanwhile, the n-
hexane and chloroform extracts displayed moderate antioxidant 
properties with 59% and 69% inhibitions, respectively (Yosie et 
al., 2011). 
Various in vitro model systems such as ferric thiocyanate, 
thiobarbituric acid, DPPH, ferric-reducing antioxidant power 
(FRAP) and nitric oxide (NO) scavenging method were used to 
characterize the antioxidant properties of different parts of the 
fruits. The results revealed the strong antioxidant properties of 
the pericarp and mesocarp in the FRAP assays with percentage 
inhibition of 92.35% and 78.78%, respectively (Hendra et al., 
2011). In addition, antioxidant study of 2,6,4'-trihydroxy-4-
methoxybenzophenone (8) and macronone (26) performed 
using the DPPH method. Interestingly, compound (8) displayed 
strong antioxidant properties (IC50 10.57 µg/ml) while 
macronone (26) had weak activity (IC50 240.14 µg/ml) 
(Susilawati et al., 2011; 2012). 
 
Antimicrobial activities 
Antibacterial activity of various parts of P. macrocarpa fruits 
was studied using the disc diffusion method against eight 
bacterial strains, i.e., Bacillus cereus, Bacillus subtilis, 
Enterobacter aerogenes, Escherichia coli, Klebsiela pneumonie, 
Micrococcus luteus, Pseodomonas aeruginosa and 
Staphylococcus aureus. All parts including the pericarp, 
mesocarp and seeds exhibited weak to moderate antibacterial 
activity against all pathogenic bacteria strains with inhibition 
zones ranging from 9.3 – 23.3 mm (Hendra et al., 2011). In the 
same study, the antifungal activity was evaluated using the agar 
well diffusion assay against Aspergillus niger, Fusarium 
Table 3. Summary of pharmacological activities of extracts from P. macrocarpa (continued) 
Activity Extract Plant part 
Assay / 
Method 
Organism / cells used Results / observation Reference 
Antibacterial 
activity 
Methanol 
Pericarp, 
mesocarp 
and seed 
Disc 
diffusion 
method 
B. cereus, B. subtilis, 
E. aerogenes, E. coli, 
K. pneumonie, M. 
luteus, P. aeruginosa 
and S. aureus 
All parts including pericarp, 
mesocarp and seed were exhibited 
weak to moderate antibacterial 
activity against all pathogenic tested 
bacteria with inhibition zone 
ranging from 0.93 cm – 2.33 cm. 
Hendra et al., 
2011 
n-Hexane, 
chloroform, 
ethyl 
acetate and 
methanol 
Leaves 
Mueller 
Hinton agar 
well 
diffusion 
method 
E. coli, K. pneumonia, 
P. aeruginosa, S. 
ubellis, S. aureus and 
B. cereus 
The highest activity was shown by 
ethyl acetate and methanol extracts 
against B. cereus and S. aureus with 
inhibition zone diameter ranging 
between 15 mm – 27 mm. 
Yosie et al., 
2011 
Antifungal 
activity 
Methanol 
Pericarp, 
mesocarp 
and seed 
Agar well 
diffusion 
assay 
A.niger, F.oxysporum, 
G. lucidum and M. 
indicus 
The results showed that only seed 
extract was displayed antifungal 
properties against A. niger at 
concentration of 0.3 mg/well. 
Hendra et al., 
2011 
Vasorelaxant 
activity 
 
Chloroform 
and 
methanol 
Fruits 
Vasodilator 
assay 
Noradrenaline-
induced contraction of 
isolated rat aorta 
The results demonstrated the 
moderate vasorelaxant activity of 
chloroform extract. 
Oshimi et al., 
2008 
Antihyper-
tensive 
activity 
Petroleum 
ether, ethyl 
acetate and 
methanol 
Fruits and 
leaves 
Inhibitory 
activity 
Angiotensin 
converting enzyme 
(ACE) 
All extracts from the fruits and 
leaves were found to have the 
highest inhibitory activity against 
ACE with IC50 ranging between 102 
– 189 µg/ml. 
Rinayanti et 
al., 2013 
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oxysporum, Ganoderma lucidum and Mucor indicus. The 
results showed that only seed extract was active against A. 
niger at a concentration of 0.3 mg/well (Hendra et al., 2011). 
Different polarities of extracts from the leaves of P. 
macrocarpa including the n-hexane, chloroform, ethyl acetate 
and methanol extracts were evaluated for their antibacterial 
activity against E. coli, K. pneumonia, P. aeruginosa, 
Streptococcus ubellis, Streptococcus aureus and B. cereus. 
Mueller Hinton agar well diffusion method was used to 
determine the susceptibility of bacteria tests. The highest 
activity was shown by ethyl acetate and methanol extracts 
against B. cereus and S. aureus with inhibition zone diameter 
ranging between 1527 mm (Yosie et al., 2011). 
 
Toxicity 
The general toxicity of 29-norcucurbitacin derivatives; 
desacetyl-fevicordin A (14), fevicordin A (15), fevicordin A 
glucoside (16) and fevicordin D glucoside (17), isolated from 
this plant was evaluated by the brine shrimp (Artemia salina) 
lethality assay. All compounds showed variable general toxicity 
with LD50 values ranging from 3 – 12 ppm (Kurnia et al., 2008). 
 
Vasorelaxant activity 
The vasorelaxant activity of the extracts and compounds (1, 9, 
28) isolated from the fruits of P. macrocarpa was evaluated 
against noradrenaline-induced contraction of isolated rat aorta. 
The results demonstrated the moderate vasorelaxant activity of 
the chloroform extract, while icariside C3 (9) showed a slow 
vasorelaxant activity. Phalerin (1) and mangiferin (28) did not 
show any vasorelaxant effect (Oshimi et al., 2008). 
 
Antihypertensive activity 
Study on the antihypertensive activity of nine medicinal plants 
from Indonesia was conducted against angiotensin converting 
enzyme. The nine tested plants were Scurulla artopurpurea, 
catharanthus roseus, Swietenia mahogany, Persea Americana, 
Oxalis corniculata, P. macrocarpa, Gynura procumbens, Melia 
azedarach and Hisbiscus rosasinensisi. Interestingly, all 
extracts from the fruits and leaves of P. macrocarpa displayed 
the highest level of inhibitory activity against acetylcholine 
esterase with IC50 ranging between 102 – 189 µg/ml (Rinayanti 
et al., 2013).  
 
 
CONCLUSION 
 
In this review, we have reviewed the relevant literature to 
assemble the ethnomedicinal, phytochemical and 
pharmacological properties of P. macrocarpa (Scheff). Boerl. 
This plant is used as folk remedies in both traditional as well as 
modern system of medicine to treat various diseases and 
illnesses. Various types of compounds with diverse chemical 
structures present in this plant are responsible for varied 
pharmacological and medicinal properties. Reported data show 
that the plant possesses promising anticancer, antidiabetic, anti-
inflammatory, antioxidant, antimicrobial, antihypertensive, 
toxicity and vasorelaxant activities. However, in view of the 
wide range of medicinal uses of P. macrocarpa, it is necessary 
to conduct further clinical and pharmacological studies at 
molecular level to investigate the potential of this plant, 
because most of the activity reported is based only on their in 
vitro assays. Similarly, additional studies have to be carried out 
in order to establish the potential of the extracts of P. 
macrocarpa in the development of new therapeutic drugs and 
to provide the basis for future research on the application of 
medicinal plants. 
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